VVOS Key Statistics, Chart & Performance
The current stock price of VVOS is 1.99 USD. In the past month the price increased by 6.15%. In the past year, price decreased by -63.94%.
VVOS Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to VVOS. When comparing the yearly performance of all stocks, VVOS is a bad performer in the overall market: 94.07% of all stocks are doing better.
VVOS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to VVOS. VVOS may be in some trouble as it scores bad on both profitability and health.
VVOS Financial Highlights
Over the last trailing twelve months VVOS reported a non-GAAP Earnings per Share(EPS) of -1.77. The EPS increased by 68.84% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -66.7% | ||
| ROE | -675.51% | ||
| Debt/Equity | 3.36 |
VVOS Forecast & Estimates
9 analysts have analysed VVOS and the average price target is 5.1 USD. This implies a price increase of 156.28% is expected in the next year compared to the current price of 1.99.
For the next year, analysts expect an EPS growth of 33.4% and a revenue growth 24.91% for VVOS
VVOS Ownership
VVOS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.66 | 101.40B | ||
| CI | THE CIGNA GROUP | 9.53 | 72.29B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 128.01 | 23.55B | ||
| LH | LABCORP HOLDINGS INC | 17.2 | 22.56B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.34 | 20.99B | ||
| GH | GUARDANT HEALTH INC | N/A | 14.75B | ||
| DVA | DAVITA INC | 11.25 | 7.33B | ||
| HIMS | HIMS & HERS HEALTH INC | 56.78 | 6.98B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 37.83 | 6.96B | ||
| CHE | CHEMED CORP | 20.48 | 6.38B | ||
| OPCH | OPTION CARE HEALTH INC | 24.05 | 5.69B | ||
| RDNT | RADNET INC | 185.71 | 5.44B |
Related stock screener links
About VVOS
Company Profile
Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). The company is headquartered in Littleton, Colorado and currently employs 109 full-time employees. The company went IPO on 2020-12-11. The firm's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The firm's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The firm has sleep testing centers and associated medical sleep practice.
Company Info
VIVOS THERAPEUTICS INC
7921 Southpark Plaza,, Suite 210
Littleton COLORADO US
Employees: 109
Phone: 18669084867
VIVOS THERAPEUTICS INC / VVOS FAQ
What does VIVOS THERAPEUTICS INC do?
Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). The company is headquartered in Littleton, Colorado and currently employs 109 full-time employees. The company went IPO on 2020-12-11. The firm's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The firm's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The firm has sleep testing centers and associated medical sleep practice.
Can you provide the latest stock price for VIVOS THERAPEUTICS INC?
The current stock price of VVOS is 1.99 USD. The price decreased by -3.86% in the last trading session.
Does VIVOS THERAPEUTICS INC pay dividends?
VVOS does not pay a dividend.
What is the ChartMill technical and fundamental rating of VVOS stock?
VVOS has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the expected growth for VVOS stock?
The Revenue of VIVOS THERAPEUTICS INC (VVOS) is expected to grow by 24.91% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the number of employees for VIVOS THERAPEUTICS INC?
VIVOS THERAPEUTICS INC (VVOS) currently has 109 employees.